Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Akinori Asagi"'
Autor:
Takumasa Takemoto, Ikuko Kiriyama, Yoshifumi Sugawara, Chie Abe, Norihiro Teramoto, Katsuyoshi Hashine, Isao Yoshida, Akinori Asagi
Publikováno v:
Radiology Case Reports, Vol 19, Iss 6, Pp 2224-2229 (2024)
Adrenal leiomyomas are rare and often reported as Epstein-Barr virus (EBV)-associated smooth muscle tumor (SMT) in association with EBV infection in immunocompromised patients. We experienced a case of right adrenal leiomyoma that was incidentally fo
Externí odkaz:
https://doaj.org/article/91ac245ed1f049de8fc0d20632890b50
Autor:
Hiroshi Imaoka, Masafumi Ikeda, Shogo Nomura, Chigusa Morizane, Takuji Okusaka, Masato Ozaka, Satoshi Shimizu, Kentaro Yamazaki, Naohiro Okano, Kazuya Sugimori, Hirofumi Shirakawa, Nobumasa Mizuno, Sohei Satoi, Hironori Yamaguchi, Rie Sugimoto, Kunihito Gotoh, Keji Sano, Akinori Asagi, Kazuyoshi Nakamura, Makoto Ueno
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract The prognosis of advanced biliary tract cancer (BTC) patients remains poor due to limited efficacy of chemotherapy and difficulties in management. Thus, prediction of survival is crucial for the clinical management of advanced BTC. The aim w
Externí odkaz:
https://doaj.org/article/e3baf138902d49fc89d0cce9781a3f2f
Autor:
Satoshi Shiba, Hiroshi Imaoka, Kazuhiko Shioji, Eiichiro Suzuki, Shigeru Horiguchi, Takeshi Terashima, Yasushi Kojima, Tatsuya Okuno, Yasutaka Sukawa, Kunihiko Tsuji, Kumiko Umemoto, Akinori Asagi, Akiko Todaka, Makoto Ueno, Masafumi Ikeda, Chigusa Morizane, Junji Furuse
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Epithelioid hemangioendothelioma is an exceedingly rare sarcoma often occurring as an indolent angiocentric vascular tumor at various anatomic sites. Few reports have evaluated large case series of epithelioid hemangioendothelioma
Externí odkaz:
https://doaj.org/article/f9cce50e46fb42bb9944e91911e7b36a
Autor:
Yukio Yoshida, Satoshi Kobayashi, Makoto Ueno, Chigusa Morizane, Kunihiro Tsuji, Yuta Maruki, Keita Mori, Kazuo Watanabe, Akihiro Ohba, Mitsuhiro Furuta, Akiko Todaka, Akiko Tsujimoto, Masato Ozaka, Naohiro Okano, Kei Yane, Kumiko Umemoto, Yasuyuki Kawamoto, Takeshi Terashima, Hidetaka Tsumura, Keitaro Doi, Kazuhiko Shioji, Akinori Asagi, Yasushi Kojima, Eiichiro Suzuki, Reishi Toshiyama, Masayuki Furukawa, Atsushi Naganuma, Rei Suzuki, Haruo Miwa, Masafumi Ikeda, Junji Furuse
Publikováno v:
Pancreatology. 22:1159-1166
Pancreatic adenosquamous carcinoma (PASC) is a rare variant of pancreatic ductal adenocarcinoma (PDAC). The usual treatment for metastatic or recurrent PASC is systemic chemotherapy in accordance with the PDAC treatment strategy. This study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894faff9343056be854bedd12bdf618a
https://doi.org/10.1016/j.pan.2022.09.236
https://doi.org/10.1016/j.pan.2022.09.236
Autor:
Kaori, Hino, Tomohiro, Nishina, Yuuki, Numata, Akinori, Asagi, Tomonori, Inoue, Megumi, Yoshimatsu, Chihiro, Sakaguchi, Akio, Nakasya, Norifumi, Nishide, Takeshi, Kajiwara, Takashi, Terao, Seijin, Nadano, Kaori, Marui, Yusuke, Okujima, Masahito, Kokubu, Yoshiki, Imamura, Kozue, Kanemitsu, Mitsuhito, Koizumi, Teru, Kumagi, Yoichi, Hiasa, Ichinosuke, Hyodo
Publikováno v:
Internal Medicine. 61:2255-2261
Objective S-1 and modified FOLFIRINOX (mFFX) were often used as the second-line chemotherapies after failure of gemcitabine plus nab-paclitaxel (GnP) in unresectable pancreatic cancer (UPC) until nanoliposomal irinotecan plus 5-fluorouracil/leucovori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37c1a7b3582a7a6ff72a10464034314
https://doi.org/10.2169/internalmedicine.8736-21
https://doi.org/10.2169/internalmedicine.8736-21
Autor:
Chihiro Sakaguchi, Tomohiro Nishina, Yoshiyasu Kono, Kaori Hino, Akinori Asagi, Yoshinori ohno, Takeshi Kajiwara, Seijin Nadano, Natsumi Yamashita, Mikiko Tohyama, Ichinosuke Hyodo, Hiroyuki Okada, Motoyuki Otsuka
Background Zinc deficiency during long-term courses of chemotherapy and its related symptoms, including skin rash, taste disorder, and oral mucositis, has not been sufficiently investigated. Methods This prospective observational study enrolled patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::297536cd2536c002dfebde0b63df5f33
https://doi.org/10.21203/rs.3.rs-2731042/v1
https://doi.org/10.21203/rs.3.rs-2731042/v1
Autor:
Masafumi Ikeda, Akinori Asagi, Masato Ozaka, Takeshi Terashima, Hiroshi Imaoka, Kazuhiko Shioji, Satoshi Kobayashi, Makoto Ueno, Hideaki Takahashi, Shigeru Horiguchi, Yasushi Kojima, Akiyoshi Kasuga, Eiichiro Suzuki, Yoshikuni Nagashio, Ryoji Takada, Chigusa Morizane, Satoshi Shiba, Junji Furuse, Kei Yane, Akiko Todaka
Publikováno v:
Pancreas. 50:77-82
Objectives The aim of this multicenter retrospective study was to identify the optimal chemotherapeutic regimen for advanced pancreatic acinar cell carcinoma (PACC). Methods Fifty-eight patients with histopathologically confirmed advanced PACC who ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::544e2927e8da7db8aad04d4fa0d588d1
https://doi.org/10.1097/mpa.0000000000001718
https://doi.org/10.1097/mpa.0000000000001718
Autor:
Junji Furuse, Kazuhiko Shioji, Hiroyuki Okuyama, Masayuki Furukawa, Motohiro Kojima, Hiroki Hara, Shinichi Ohkawa, Takuji Okusaka, Masafumi Ikeda, Yasushi Kojima, Ayumu Hosokawa, Takeharu Yamanaka, Akinori Asagi, Nobumasa Mizuno, Gou Murohisa
Publikováno v:
Neuroendocrinology. 110:988-993
Background: Platinum-containing regimens are widely used as first-line chemotherapy for unresectable pancreatic neuroendocrine carcinoma (NEC), but second-line chemotherapies have yet to be established. Objectives: We evaluated the safety and efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3430a3068f1ae750aa5ad1f78f62a4f
https://doi.org/10.1159/000505550
https://doi.org/10.1159/000505550
Autor:
Ken Kamata, R. Sugimoto, Hiroki Hara, Tatsuya Yamashita, Naohiro Okano, Hiroaki Yanagimoto, Masataka Ikeda, Masato Ozaka, Chigusa Morizane, Junji Furuse, Hiroyuki Miyakawa, Kazuhiko Shioji, Junki Mizusawa, Kazuya Sugimori, Keita Wada, Naoya Kato, Ayumu Hosokawa, Shoji Nakamori, Ken Kawabe, Tomohisa Iwai, Tatsuya Ioka, Toshio Nakagohri, Kazutoshi Tobimatsu, Hiroshi Ishii, Makoto Ueno, Hironori Yamaguchi, Seigo Yukisawa, Yasuyuki Kawamoto, T. Okusaka, Y. Kojima, K. Yane, Nobumasa Mizuno, Hiroshi Katayama, Kenji Nakamura, Ken Shimizu, Akira Fukutomi, Akinori Asagi
Publikováno v:
Annals of Oncology. 30:1950-1958
Background Gemcitabine plus cisplatin (GC) is the standard treatment of advanced biliary tract cancer (BTC); however, it causes nausea, vomiting, and anorexia, and requires hydration. Gemcitabine plus S-1 (GS) reportedly has equal to, or better, effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7732c21fd364d7901e3a2c441011d666
https://doi.org/10.1093/annonc/mdz402
https://doi.org/10.1093/annonc/mdz402
Autor:
AKIKO TODAKA, SATOSHI NARA, FUYUHIKO MOTOI, SOICHIRO MORINAGA, REISHI TOSHIYAMA, RYOTA HIGUCHI, MASARU KONISHI, HIROFUMI SHIRAKAWA, HIDETAKA TSUMURA, HIROYUKI OKUYAMA, HIROAKI NAGANO, KAZUHIKO SHIOJI, KEISHI SUGIMACHI, AKINORI ASAGI, NOBUMASA MIZUNO, JUNJI FURUSE
Publikováno v:
Anticancer research. 42(2)
We aimed to evaluate pancreatic cancer (PC) with positive peritoneal lavage cytology (CY1) outcomes following a change in adjuvant therapy.The clinicopathological data of patients with pancreatic adenocarcinoma with CY1 at 14 institutions, between 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81dbec9a0180585b2cc59ec4d6816fd8
https://pubmed.ncbi.nlm.nih.gov/35093887
https://pubmed.ncbi.nlm.nih.gov/35093887